Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.32%461.77B | 14.69%421.71B | -2.76%1.64T | 12.32%390.41B | 4.87%439.39B | -8.46%442.66B | -15.79%367.69B | -6.94%1.69T | -19.74%347.59B | -11.12%418.98B |
Cost of revenue | -0.16%262.76B | 12.63%252.26B | -0.98%1T | 6.14%246.08B | 12.08%270.12B | -6.98%263.19B | -13.02%223.98B | -2.97%1.01T | -9.83%231.84B | -10.66%240.99B |
Gross profit | 10.89%199.01B | 17.91%169.45B | -5.45%636.8B | 24.69%144.34B | -4.89%169.28B | -10.55%179.47B | -19.78%143.71B | -12.33%673.53B | -34.21%115.76B | -11.73%177.99B |
Operating expense | 18.26%107.22B | 10.12%103.07B | -1.47%375.07B | -4.12%97.73B | -6.49%93.08B | -0.17%90.66B | 5.89%93.6B | 10.61%380.68B | 15.96%101.93B | 13.47%99.54B |
Staff costs | ---- | ---- | 0.24%128.42B | ---- | ---- | ---- | ---- | --128.11B | ---- | ---- |
Selling and administrative expenses | 11.72%65.3B | 14.32%69.84B | -16.79%66.05B | -3.11%-114.42B | -12.70%60.93B | -3.32%58.45B | 1.65%61.09B | -65.91%79.38B | -287.79%-110.97B | 17.29%69.79B |
-Selling and marketing expense | ---- | ---- | 11.80%4.37B | ---- | ---- | ---- | ---- | --3.91B | ---- | ---- |
-General and administrative expense | 11.72%65.3B | 14.32%69.84B | -18.27%61.68B | -3.41%-118.78B | -12.70%60.93B | -3.32%58.45B | 1.65%61.09B | -67.59%75.47B | -294.41%-114.87B | 17.29%69.79B |
Research and development costs | 6.27%35.71B | 15.65%37.85B | 6.29%132.5B | 0.94%32.7B | 10.12%33.46B | 7.21%33.61B | 7.22%32.73B | 12.01%124.66B | 12.45%32.4B | 7.67%30.39B |
Depreciation and amortization | ---- | ---- | 3.65%32.94B | ---- | ---- | ---- | ---- | --31.78B | ---- | ---- |
-Depreciation | ---- | ---- | 3.65%32.94B | ---- | ---- | ---- | ---- | --31.78B | ---- | ---- |
Other operating expenses | 647.04%8.85B | 247.20%3.91B | -5.41%19.16B | -4.18%16.7B | -81.24%154M | -24.15%1.18B | 150.00%1.13B | --20.26B | --17.43B | --821M |
Total other operating income | 2.28%2.64B | 535.65%8.52B | 14.14%4.01B | 56.54%-1.38B | 0.34%1.46B | 1.17%2.58B | -49.85%1.34B | --3.51B | ---3.17B | --1.45B |
Operating profit | 3.36%91.8B | 32.46%66.38B | -10.63%261.73B | 237.09%46.61B | -2.86%76.2B | -19.14%88.81B | -44.78%50.11B | -30.94%292.86B | -84.29%13.83B | -31.14%78.44B |
Net non-operating interest income (expenses) | -217.71%-11.35B | 35.70%17.18B | 110.84%11.27B | -44.67%955M | 6.17%-11.99B | 148.10%9.65B | 1.18%12.66B | 510.63%5.34B | 1,427.43%1.73B | -4,170.38%-12.78B |
Non-operating interest income | ---- | ---- | 121.79%13.21B | 642.54%1.24B | 167.43%3.02B | 83.74%10B | ---- | 399.33%5.96B | -213.43%-228M | 193.51%1.13B |
Non-operating interest expense | ---- | ---- | 33.85%1.57B | 92.92%-99M | 7.94%15.02B | -77.28%353M | ---- | 267.92%1.17B | -1,688.64%-1.4B | 19,492.96%13.91B |
Total other finance cost | ---- | -35.70%-17.18B | 168.53%381M | ---- | ---- | ---- | ---12.66B | ---556M | ---- | ---- |
Net investment income | 1,232.66%13.22B | 277.19%992M | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | -1.11B | 0 | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 129.42%554M | -1.88B | ||||||||
Income from associates and other participating interests | 2,100.00%20M | 15M | 31M | 26M | 6M | -1M | 0 | 0 | 0 | 0 |
Special income (charges) | -2,200.22%-48.31B | 2.3B | ||||||||
Less:Other special charges | ---- | ---- | 56.89%-1.24B | ---- | ---- | ---- | ---- | ---2.88B | ---- | ---- |
Less:Write off | ---- | ---- | 8,457.17%49.55B | ---- | ---- | ---- | ---- | --579M | ---- | ---- |
Other non-operating income (expenses) | -34.21%2.02B | -59.02%3.08B | ||||||||
Income before tax | -18.28%80.46B | 33.13%83.57B | -20.91%239.4B | -30.28%13.97B | -2.21%64.21B | -13.42%98.46B | -39.21%62.77B | -30.05%302.68B | -77.70%20.04B | -42.91%65.66B |
Income tax | -27.22%17.09B | 34.80%17.29B | 0.06%59.07B | 171.13%7.85B | 1.56%14.92B | -16.41%23.48B | -53.02%12.83B | -50.32%59.04B | -142.10%-11.04B | -54.70%14.69B |
Net income | -15.48%63.38B | 32.71%66.28B | -25.99%180.34B | -80.31%6.12B | -3.30%49.29B | -12.45%74.98B | -34.25%49.94B | -22.38%243.65B | -51.15%31.07B | -38.28%50.98B |
Net income continuous operations | -15.48%63.38B | 32.71%66.28B | -25.99%180.34B | -80.31%6.12B | -3.30%49.29B | -12.45%74.98B | -34.25%49.94B | -22.38%243.65B | -51.15%31.07B | -38.28%50.98B |
Noncontrolling interests | -681.08%-578M | 43.59%-88M | -68.46%-502M | -298.08%-207M | 12.33%-64M | -15.63%-74M | -43.12%-156M | -21.63%-298M | 29.73%-52M | -37.74%-73M |
Net income attributable to the company | -14.79%63.96B | 32.47%66.37B | -25.87%180.84B | -79.68%6.33B | -3.31%49.36B | -12.43%75.06B | -34.14%50.1B | -22.34%243.95B | -51.13%31.13B | -38.23%51.05B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -14.79%63.96B | 32.47%66.37B | -25.87%180.84B | -79.68%6.33B | -3.31%49.36B | -12.43%75.06B | -34.14%50.1B | -22.34%243.95B | -51.13%31.13B | -38.23%51.05B |
Gross dividend payment | ||||||||||
Basic earnings per share | 157.87%34.15 | 33.11%35.3 | -25.59%95.72 | -79.77%3.35 | -3.29%26.13 | -12.12%13.2433 | -33.36%26.52 | -21.39%128.64 | -50.09%16.56 | -37.25%27.02 |
Diluted earnings per share | 157.84%34.1452 | 33.11%35.3 | -25.59%95.72 | -79.68%3.3484 | -3.29%26.13 | -12.12%13.243 | -33.36%26.52 | -21.39%128.64 | -50.34%16.476 | -37.25%27.02 |
Dividend per share | 8.00%27 | 0 | 4.00%52 | 8.00%27 | 0 | 0.00%25 | 0 | 15.38%50 | 7.14%25 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |